GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (HAM:8SV) » Definitions » Deferred Tax

WPD Pharmaceuticals (HAM:8SV) Deferred Tax : €0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is WPD Pharmaceuticals Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

WPD Pharmaceuticals's change in deferred tax for the three months ended in Sep. 2024 was €0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00 Mil.

WPD Pharmaceuticals Deferred Tax Historical Data

The historical data trend for WPD Pharmaceuticals's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals Deferred Tax Chart

WPD Pharmaceuticals Annual Data
Trend Jan13 Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

WPD Pharmaceuticals Quarterly Data
Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

WPD Pharmaceuticals Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WPD Pharmaceuticals Deferred Tax Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

WPD Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (HAM:8SV) » Definitions » Deferred Tax
Comparable Companies
VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170 OCSE:GMAB INSM BMRN HKSE:02269 SHSE:603392 INCY HKSE:09926
Traded in Other Exchanges
WBIO:Canada
Address
700-595 Burrard Street, Suite 401, Vancouver, BC, CAN, V7X 1S8
Website
https://www.wpdpharmaceuticals.com
WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, virology, research, and development of medicinal products involving biological compounds and small molecules.

WPD Pharmaceuticals Headlines

No Headlines